166 related articles for article (PubMed ID: 17953775)
1. Modelling the evolution of drug resistance in the presence of antiviral drugs.
Wu J; Yan P; Archibald C
BMC Public Health; 2007 Oct; 7():300. PubMed ID: 17953775
[TBL] [Abstract][Full Text] [Related]
2. Antiviral resistance and the control of pandemic influenza.
Lipsitch M; Cohen T; Murray M; Levin BR
PLoS Med; 2007 Jan; 4(1):e15. PubMed ID: 17253900
[TBL] [Abstract][Full Text] [Related]
3. Hedging against antiviral resistance during the next influenza pandemic using small stockpiles of an alternative chemotherapy.
Wu JT; Leung GM; Lipsitch M; Cooper BS; Riley S
PLoS Med; 2009 May; 6(5):e1000085. PubMed ID: 19440354
[TBL] [Abstract][Full Text] [Related]
4. Antiviral resistance and the control of pandemic influenza: the roles of stochasticity, evolution and model details.
Handel A; Longini IM; Antia R
J Theor Biol; 2009 Jan; 256(1):117-25. PubMed ID: 18952105
[TBL] [Abstract][Full Text] [Related]
5. Modeling the effects of drug resistant influenza virus in a pandemic.
Brockmann SO; Schwehm M; Duerr HP; Witschi M; Koch D; Vidondo B; Eichner M
Virol J; 2008 Oct; 5():133. PubMed ID: 18973656
[TBL] [Abstract][Full Text] [Related]
6. Emergence of drug resistance: implications for antiviral control of pandemic influenza.
Alexander ME; Bowman CS; Feng Z; Gardam M; Moghadas SM; Röst G; Wu J; Yan P
Proc Biol Sci; 2007 Jul; 274(1619):1675-84. PubMed ID: 17507331
[TBL] [Abstract][Full Text] [Related]
7. Antiviral resistance during pandemic influenza: implications for stockpiling and drug use.
Arino J; Bowman CS; Moghadas SM
BMC Infect Dis; 2009 Jan; 9():8. PubMed ID: 19161634
[TBL] [Abstract][Full Text] [Related]
8. The use of mathematical models to inform influenza pandemic preparedness and response.
Wu JT; Cowling BJ
Exp Biol Med (Maywood); 2011 Aug; 236(8):955-61. PubMed ID: 21727183
[TBL] [Abstract][Full Text] [Related]
9. Monitoring the fitness of antiviral-resistant influenza strains during an epidemic: a mathematical modelling study.
Leung K; Lipsitch M; Yuen KY; Wu JT
Lancet Infect Dis; 2017 Mar; 17(3):339-347. PubMed ID: 27914853
[TBL] [Abstract][Full Text] [Related]
10. Emergence of drug-resistant influenza virus: population dynamical considerations.
Regoes RR; Bonhoeffer S
Science; 2006 Apr; 312(5772):389-91. PubMed ID: 16627735
[TBL] [Abstract][Full Text] [Related]
11. Post-exposure prophylaxis during pandemic outbreaks.
Moghadas SM; Bowman CS; Röst G; Fisman DN; Wu J
BMC Med; 2009 Dec; 7():73. PubMed ID: 19954514
[TBL] [Abstract][Full Text] [Related]
12. Drivers and consequences of influenza antiviral resistant-strain emergence in a capacity-constrained pandemic response.
Dafilis MP; Moss R; McVernon J; McCaw J
Epidemics; 2012 Dec; 4(4):219-26. PubMed ID: 23351374
[TBL] [Abstract][Full Text] [Related]
13. Modeling the global transmission of antiviral-resistant influenza viruses.
Chao DL
Influenza Other Respir Viruses; 2013 Jan; 7 Suppl 1(Suppl 1):58-62. PubMed ID: 23279898
[TBL] [Abstract][Full Text] [Related]
14. Antiviral prophylaxis during pandemic influenza may increase drug resistance.
Eichner M; Schwehm M; Duerr HP; Witschi M; Koch D; Brockmann SO; Vidondo B
BMC Infect Dis; 2009 Jan; 9():4. PubMed ID: 19154598
[TBL] [Abstract][Full Text] [Related]
15. Modeling the worldwide spread of pandemic influenza: baseline case and containment interventions.
Colizza V; Barrat A; Barthelemy M; Valleron AJ; Vespignani A
PLoS Med; 2007 Jan; 4(1):e13. PubMed ID: 17253899
[TBL] [Abstract][Full Text] [Related]
16. Novel antiviral drug discovery strategies to tackle drug-resistant mutants of influenza virus strains.
Shin WJ; Seong BL
Expert Opin Drug Discov; 2019 Feb; 14(2):153-168. PubMed ID: 30585088
[TBL] [Abstract][Full Text] [Related]
17. Oseltamivir-resistant pandemic (H1N1) 2009 influenza virus, October 2009.
Wkly Epidemiol Rec; 2009 Oct; 84(44):453-9. PubMed ID: 19894344
[No Abstract] [Full Text] [Related]
18. FAO-OIE-WHO Joint Technical Consultation on Avian Influenza at the Human-Animal Interface.
Anderson T; Capua I; Dauphin G; Donis R; Fouchier R; Mumford E; Peiris M; Swayne D; Thiermann A
Influenza Other Respir Viruses; 2010 May; 4 Suppl 1(Suppl 1):1-29. PubMed ID: 20491978
[TBL] [Abstract][Full Text] [Related]
19. Impact of emerging antiviral drug resistance on influenza containment and spread: influence of subclinical infection and strategic use of a stockpile containing one or two drugs.
McCaw JM; Wood JG; McCaw CT; McVernon J
PLoS One; 2008 Jun; 3(6):e2362. PubMed ID: 18523549
[TBL] [Abstract][Full Text] [Related]
20. Emergence of drug resistance during an influenza epidemic: insights from a mathematical model.
Stilianakis NI; Perelson AS; Hayden FG
J Infect Dis; 1998 Apr; 177(4):863-73. PubMed ID: 9534957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
